APO + SRL
1.0 FTEAPO + reported total assets of 364,448 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 1 full-time equivalent.
The score of APO + shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +2 % Total assets -8 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
APO +'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −8,137 € | ||||
| Equity | 257,117 € | ||||
| Cash | 32,764 € | ||||
| EBITDA | 18,616 € | ||||
| Total assets | 364,448 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jun 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
APO +'s financial analysis
- Solvency70.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of APO +
APO +'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0882.216.483
- VAT number
- BE0882216483
- Peppol
- Registered · 0208:0882216483 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Jun 2006
- Registered office
- 2100 Antwerp
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
APO + (SRL) has been based in Antwerp since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 8,137 € and equity of 257,117 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 70.5%, above the median of its sector (44.2%).
Companies similar to APO +
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de la Fougeraie Retail sale of pharmaceutical products Ans · balance sheet 364,712 €
- PHLV Retail sale of pharmaceutical products Bornem · balance sheet 363,992 €
- Apotheek Veldstraat Retail sale of pharmaceutical products Ghent · balance sheet 365,048 €
- Cobea Pharma Retail sale of pharmaceutical products Villers-la-Ville · balance sheet 362,823 €
- Acura Pharma Retail sale of pharmaceutical products Brussels · balance sheet 366,408 €
- Charlotte DE Chaffoy Retail sale of pharmaceutical products Brussels · balance sheet 361,413 €
- Bogest Retail sale of pharmaceutical products Liège · balance sheet 367,587 €
- Brupharma Retail sale of pharmaceutical products Bruges · balance sheet 360,003 €
Frequently asked questions about APO +
What is the revenue of APO +?
APO + files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of APO +?
In Belgium, the VAT number is the company number prefixed with BE: BE0882216483 for APO +, if the company is VAT-registered. Its company number (CBE) is 0882.216.483.
Where is the registered office of APO +?
According to the CBE register, the registered office of APO + is in 2100 Antwerp.
What is the equity of APO +?
At the close of the 2025 financial year, the equity of APO + amounts to 257,117 €, a solvency of 70.5% of total assets.
How many people work at APO +?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages APO +?
The register lists 1 active mandates at APO +. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of APO +
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →